Senegal
A $45 million investment has been announced to support vaccine production in Senegal.
The U.S. Development Finance Corporation (DFC), the African Development Bank (AfDB), and the International Finance Corporation (IFC) have joined forces to fund VaxSen, the vaccine production and distribution arm of the Pasteur Institute in Dakar.
The agreement, signed on December 13th in the presence of Senegalese President Bassirou Diomaye Faye, underscores Senegal's leadership in advancing public health goals across the continent.
The funding will enhance local vaccine production, strengthen supply chains, and establish a solid network for vaccine distribution.
This aligns with the African Union’s Vision 2040, which aims for Africa to locally produce 60% of its vaccine needs.
01:54
UN and AU deepen partnership to synchronize agendas and end continent's conflicts
00:47
African Union says continent's rising debt crisis undermines development
00:54
A third of Japan-donated Mpox vaccines wasted in DRC due to storage challenges
01:31
South Africa starts clinical trials on first locally developed oral cholera vaccine
00:54
Mali: African Union Commission calls for urgent international action on security crisis
01:23
African Union monitors say Tanzanian poll did not meet international standards